Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Email me when S 5316 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track S 5316. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The BINSA Act amends the Defense Production Act to treat biotech research, development, manufacturing and related intellectual property as a controlled technology. It forces the Treasury to define the biotech scope within a year and requires the Defense Department to report on U.S. capital flowing into Chinese biotech firms. The goal is to prevent strategic dependence on China for pharmaceutical and therapeutic capabilities.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about S 5316
3 free questions a day, no accountSponsors
- Sen. Ricketts, Pete [R-NE] (R) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when S 5316 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track S 5316 freeOr ask your AI assistant about S 5316 directly:
Add to Claude, ChatGPT or Cursor